Deep Track Capital, LP Kal Vista Pharmaceuticals, Inc. Transaction History

Deep Track Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$8.16 - $15.1 $769,022 - $1.42 Million	94,243 Added 5.45%	1,824,000 $17.9 Million
Q1 2022 May 16, 2022	BUY	$11.2 - $16.97 $2.57 Million - $3.9 Million	229,757 Added 15.32%	1,729,757 $25.5 Million
Q4 2021 Feb 14, 2022	BUY	$12.36 - $18.28 $18.5 Million - $27.4 Million	1,500,000 New	1,500,000 $19.8 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.